ICH E6 (R3) Guideline on good clinical practice (GCP)
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
23 January 2025. Date for coming into effect 23 July 2025
ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
The overarching principles and Annex 1, adopted by ICH and CHMP, came into effect on 23 July 2025.
With the public consultation now concluded, the Annex 2 is expected to be finalised later in 2025.
I. INTRODUCTION
II. PRINCIPLES OF ICH GCP
III. ANNEX 1
1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
2. INVESTIGATOR
3. SPONSOR
4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR
Appendix A. INVESTIGATOR’S BROCHURE
Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL
GLOSSARY
© European Medicines Agency, 2025. Reproduction is authorised provided the source is acknowledged.
Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands
Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us
Send a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000
Clinical Research News
Upcoming Clinical Trials
-
Central South UniversitySecond Xiangya Hospital of Central South University; Neuropsychiatric Institute... and other collaboratorsRecruitingGeneralized Anxiety Disorder (GAD)China
-
Gasherbrum Bio, Inc., a wholly owned subsidiary...Recruiting
-
Istituto Auxologico ItalianoGRUPPO ITALIANO MULTIDISCIPLINARE PER LO STUDIO DELLA SINCOPE (GIMSI)Not yet recruitingSyncope and Collapse
-
The University of Hong KongNot yet recruitingCoronary Artery Disease | Acute Myocardial Infarction (AMI) | Care-seekingHong Kong
-
Beth Israel Deaconess Medical CenterNot yet recruitingTrauma (Including Fractures) | Open Fracture | Ankle Fracture | Femur Fractures | Lower Extremity Fracture | Open Fracture of Tibia | Tibia Fractures | Tibia Plateau Fracture | Pilon Fractures | Polytrauma PatientsRwanda
-
Tasly Biopharmaceuticals Co., Ltd.Not yet recruitingAcute Ischemic Stroke AISChina
-
University of MichiganNot yet recruiting
-
GenAns Biotechnology Co., LtdShanghai General Hospital, ChinaNot yet recruiting
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruitingRadiation PneumonitisChina
-
Northwell HealthRecruitingInflammation | Exercise Capacity | C-reactive ProteinUnited States
-
Huazhong University of Science and TechnologyNot yet recruitingAntibiotic Prescribing for Acute Respiratory-tract InfectionsChina
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruitingElbow DislocationFrance
Clinical Research Jobs
-
United States - Ohio - Cincinnati
-
Netherlands
-
Poland - Warsaw
-
Serbia - Belgrade
-
India - Karnataka - Bengaluru
-
United States - Wilmington
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China